BioCentury
ARTICLE | Company News

AbbVie to invest $320M in manufacturing facility

February 7, 2014 1:55 AM UTC

AbbVie Inc. (NYSE:ABBV) said it will invest $320 million in a new manufacturing facility in Singapore slated to be fully operational by 2019. The facility will manufacture active drug substances for s...